Breakout Stocks of Week 39
NASDAQ was down last week (week 38) by -0.473% ending at 15,043.97 points after falling -71.52 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are TriNet Group Inc NYSE:TNET. This stock has had a buy signal since Jul 23, 2021 when the price was $73.31 and is so far up 27.75% to $93.65. Some other companies are on our watchlist to, among these are L3Harris Technologies, Inc. NYSE:LHX Finsbury Growth & Income Trust Plc XLON:FGT Boya Bio-pharmaceutical Group Co Ltd SZCE:300294 and Eagle Bancorp NASDAQ:EGBN which all got a breakout pattern emerging.
| Date | Company | Price | Week 39 |
|---|---|---|---|
| Trinet Group Inc | $93.65 | $96.37 | 2.90% |
| L3harris Technologies, Inc. | $222.46 | $223.49 | 0.463% |
| Finsbury Growth & Income Trust Plc | £899.00 | £900.00 | 0.111% |
| Boya Bio-pharmaceutical Group Co Ltd | ¥38.19 | ¥36.76 | -3.74% |
| Eagle Bancorp | $54.08 | $55.16 | 2.00% |
The TriNet Group Inc stock price gained 0.300% on the last trading day (Friday, 17th Sep 2021), rising from $93.37 to $93.65. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.65% from a day low at $93.19 to a day high of $94.73. The price has risen in 5 of the last 10 days and is up by 1.02% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 359 thousand more shares were traded than the day before. In total, 508 thousand shares were bought and sold for approximately $47.58 million.
On Mar 04, 2024, it was reported that Needham gave TNET a "Buy" grade with a "hold" action.
TriNet Group Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About TriNet Group Inc:
TriNet Group, Inc. provides human resources (HR) solutions, payroll services, employee benefits, and employment risk mitigation services for small and midsize businesses in the United States. The company offers multi-state payroll processing and tax administration; employee benefits programs, including health insurance and retirement plans; workers compensation insurance and claims management; employment and benefits law compliance; and other HR related services. It serves clients in various industries, including technology, professional services, financial services, life sciences, not-for-profit, property management, retail, manufacturing, and hospitality. The company sells its solutions through its direct sales organization. TriNet Group, Inc. was incorporated in 1988 and is headquartered in Dublin, California.
The L3Harris Technologies, Inc. stock price gained 0.647% on the last trading day (Friday, 17th Sep 2021), rising from $221.03 to $222.46. During the last trading day the stock fluctuated 1.34% from a day low at $220.67 to a day high of $223.62. The price has fallen in 6 of the last 10 days and is down by -5% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 790 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $492.78 million.
On Apr 22, 2024, it was reported that Alembic Global gave LHX a "Overweight" grade with a "upgrade" action.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About L3Harris Technologies, Inc.:
L3Harris Technologies, Inc., an aerospace and defense technology company, provides mission-critical solutions for government and commercial customers worldwide. The company's Integrated Mission Systems segment provides multi-mission intelligence, surveillance, and reconnaissance (ISR) systems; and communication systems, as well as fleet management support, sensor development, modification, and periodic depot maintenance services for ISR and airborne missions. It also manufactures and integrates mission systems for maritime platforms, such as signals intelligence and multi-intelligence platforms; unmanned surface and undersea autonomous solutions; and power and ship control systems and other electronic and electrical products and systems. In addition, this segment offers advanced electro-optical and infrared solutions. Its Space and Airborne Systems segment offers space payloads, sensors, and full-mission solutions; classified intelligence and cyber defense solutions; mission avionics; and electronic warfare systems. The company's Communication Systems segment provides tactical communications; broadband secured mobile networked communication equipment, including airborne, space, and surface data link terminals, ground stations, and transportable tactical satellite communication (SATCOM) systems for use in manned aircraft, unmanned aerial vehicles, and naval ships; and helmet and weapon mounted integrated night vision systems. This segment also offers radios, systems applications, and equipment for critical public safety and professional communications; and SATCOM terminals and battlefield management networks. Its Aviation Systems segment offers defense aviation products; commercial pilot training; and mission networks solutions for air traffic management. The company was formerly known as Harris Corporation and changed its name to L3Harris Technologies, Inc. in June 2019. L3Harris Technologies, Inc. was founded in 1895 and is headquartered in Melbourne, Florida.
The Finsbury Growth & Income Trust Plc stock price gained 0.672% on the last trading day (Friday, 17th Sep 2021), rising from £893.00 to £899.00. During the last trading day the stock fluctuated 1.12% from a day low at £890.00 to a day high of £900.00. The price has fallen in 5 of the last 10 days and is down by -1.32% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 213 thousand more shares were traded than the day before. In total, 659 thousand shares were bought and sold for approximately £592.82 million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Finsbury Growth & Income Trust Plc stock to perform well in the short-term period.
About Finsbury Growth & Income Trust Plc:
Finsbury Growth & Income Trust PLC is a closed ended equity mutual fund launched Frostrow Capital LLP. The fund is co-managed by Lindsell Train Limited. It invests in public equity markets of the United Kingdom. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in dividend paying value stocks of companies. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the FTSE All-Share Index. The fund was formerly known as Finsbury Growth Trust PLC. Finsbury Growth & Income Trust PLC was formed in 1926 and is domiciled in the United Kingdom.
The Boya Bio-pharmaceutical Group Co Ltd stock price gained 2.72% on the last trading day (Friday, 17th Sep 2021), rising from ¥37.18 to ¥38.19. During the last trading day the stock fluctuated 8.11% from a day low at ¥35.50 to a day high of ¥38.38. The price has been going up and down for this period, and there has been a 3.27% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately ¥351.60 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Boya Bio-pharmaceutical Group Co Ltd stock to perform well in the short-term.
About Boya Bio-pharmaceutical Group Co Ltd:
China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, diabetes medication, biochemical medication, and chemical medicine businesses in China. It engages in the research and development, production, and sales of blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, human immunoglobulin, freeze-dried intravenous human immunoglobulin, and hepatitis B human immunoglobulin; diabetes products, including metformin hydrochloride tablets/enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules; and compound osteotide, oxytocin, and heparin sodium injections for various fields, such as medicine, hepatitis, gynecology, and immunomodulation. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Fuzhou, China.
The Eagle Bancorp stock price gained 0.408% on the last trading day (Friday, 17th Sep 2021), rising from $53.86 to $54.08. During the last trading day the stock fluctuated 2.46% from a day low at $53.39 to a day high of $54.70. The price has fallen in 7 of the last 10 days and is down by -5.04% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 378 thousand more shares were traded than the day before. In total, 476 thousand shares were bought and sold for approximately $25.77 million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Eagle Bancorp:
Eagle Bancorp, Inc. operates as the bank holding company for EagleBank that provides commercial and consumer banking services primarily in the United States. The company also offers various commercial and consumer lending products comprising commercial loans for working capital, equipment purchases, real estate lines of credit, and government contract financing; asset based lending and accounts receivable financing; construction and commercial real estate loans; business equipment financing; consumer home equity lines of credit, personal lines of credit, and term loans; consumer installment loans, such as auto and personal loans; personal credit cards; and residential mortgage loans. In addition, it provides online and mobile banking services; and other services, including cash management services, business sweep accounts, lock boxes, remote deposit captures, account reconciliation services, merchant card services, safety deposit boxes, and automated clearing house origination, as well as after-hours depositories and ATM services. Further, the company offers insurance products and services through a referral program. The company serves sole proprietors, small and medium-sized businesses, partnerships, corporations, non-profit organizations and associations, and individuals, as well as investors. As of December 31, 2021, it operated seventeen banking offices comprising 6 in Suburban Maryland, 5 in the District of Columbia, and 6 in Northern Virginia. Eagle Bancorp, Inc. was incorporated in 1997 and is headquartered in Bethesda, Maryland.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
